Cited by 33Abdominal vascular conditions and treatmentsOmental and Epiploic ConditionsGastrointestinal Bleeding Diagnosis and Treatment

Nonocclusive Mesenteric Ischemia and Interventional Local Vasodilatory Therapy: A Meta-Analysis and Systematic Review of the Literature

Stahl, Klaus, Rittgerodt, Nina, Busch, Markus, Maschke, Sabine K., Schneider, Andrea, Manns, Michael P., Fuge, Jan, Meyer, Bernhard C. +3 more·2020·Journal of Intensive Care Medicine

Abstract

Background: Intensive care patients with nonocclusive mesenteric ischemia (NOMI) show mortality rates of 70% to 90%. Besides emergency surgery, different interventional local vasodilatory treatment (LVT) attempts have been described. We performed a systematic review and a meta-analysis to evaluate feasibility, efficacy, and tolerability of LVT in patients with life-threatening NOMI. Methods: Searches of PubMed, EMBASE, Web of Science, and Cochrane Library databases were performed until February 2019. Measured outcomes included immediate technical success rates (as indicated by mesenteric vasodilation on angiography or clinical improvement) and adverse events (AEs). Therapeutic efficacy was measured by the assessment of overall mortality. Results: Twelve studies (335 patients, 245 received LVT) from 1977 to 2018 were included. All studies were retrospective (4 comparative and 8 noncomparative). Different intra-arterial vasodilators (4× papaverine, 6× prostaglandin E1, 1× tolazoline/heparin, 1× tolazoline + iloprost) were reported. Initial technical success rate was 75.9% (95% confidence interval [CI], 55.1%-89%, P = .017) with an AE rate of 2.9% (95% CI: 1.3%-6.6%; P = .983). Overall mortality in LVT patients was 40.3% (95% CI: 28.7%-53%, P = .134). In 4 studies, outcomes were compared between patients receiving LVT to those who received standard of care (odds ratio for death in LVT patients was 0.261 [95% CI: 0.095-0.712, P = .009]). Conclusions: Local vasodilatory treatment appears to be safe in patients with NOMI and might have the potential to at least partially reverse mesenteric vasoconstriction features in control angiographies. However, with no randomized and prospective studies available yet, the overall quality of published studies has to be considered as low; therefore, it is not possible to draw generalizable conclusions from the present data concerning clinical end points. Its application might hold promise as a rescue treatment strategy and deserves further evaluation in randomized controlled trials.

Integrity signals

Registry

Crossref · 10.1177/0885066619879884

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stahl, K., Rittgerodt, N., Busch, M., Maschke, S. K., Schneider, A., Manns, M. P., Fuge, J., Meyer, B. C., Hoeper, M. M., Hinrichs, J. B., & David, S.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • German Center for Lung Research (DE)
Corresponding author
  • Stahl, Klaus
  • David, Sascha
Venue
Journal of Intensive Care Medicine
Published
2019-10-23
Volume
35
Issue
2
Pages
128-139
ISSN
  • 0885-0666 (ISSN-L)
  • 1525-1489
OpenAlex
W2982116067
Cited by
33
References
43
Citations by year
2026: 4 · 2025: 8 · 2024: 4 · 2022: 8 · 2021: 7 · 2020: 2
FWCI
0.88
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Intensive Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Rheumatology › Omental and Epiploic Conditions
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
nonocclusive mesenteric ischemia, mesenteric ischemia, papaverine, prostaglandin E1, tolazoline, iloprost, mesenteric vasoconstriction, technical success rate, mortality, intensive care unit patients, salvage therapy, adverse events, angiography, emergency surgery, tolerability, feasibility, efficacy, quality of evidence
MeSH terms
Critical Care, Humans, Intensive Care Units, Retrospective Studies, Vasodilation, Vasodilator Agents, Odds Ratio, Treatment Outcome, Standard of Care, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review